We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
751
DELISTED
Ansys
ANSS
| $6.97M | 0.02% |
28,968
-9,473
| -25% | -$2.21M |
|
752
Grupo Aeroportuario del Sureste
ASR
$8.15B
| $6.96M | 0.02% |
29,864
-5,170
| -15% | -$1.2M |
|
753
AMN Healthcare
AMN
$1.28B
| $6.95M | 0.02% |
67,630
-2,642
| -4% | -$304K |
|
|
OSG
754
Octave Specialty Group
OSG
$205M
| $6.94M | 0.02% |
+398,106
| New | +$5.91M |
|
755
International Bancshares
IBOC
$4.48B
| $6.93M | 0.02% |
151,401
-281,847
| -65% | -$13.6M |
|
756
PayPal
PYPL
$50.5B
| $6.91M | 0.02% |
98,605
+48,050
| +95% | +$3.85M |
|
757
Texas Capital Bancshares
TCBI
$4.36B
| $6.86M | 0.02% |
113,783
-51,352
| -31% | -$3.03M |
|
758
Alpha Metallurgical Resources
AMR
$1.95B
| $6.86M | 0.02% |
46,844
+9,155
| +24% | +$1.45M |
|
759
Avient
AVNT
$4.17B
| $6.79M | 0.02% |
201,737
+41,965
| +26% | +$1.38M |
|
760
Qiagen
QGEN
$8.81B
| $6.76M | 0.02% |
127,753
+61,286
| +92% | +$3.02M |
|
761
Jackson Financial
JXN
$8.75B
| $6.75M | 0.02% |
193,921
+89,710
| +86% | +$3.12M |
|
762
Carnival Corporation Ltd
CCL
$38B
| $6.73M | 0.02% |
835,275
-632,798
| -43% | -$5.45M |
|
763
Truist Financial
TFC
$63.9B
| $6.71M | 0.02% |
155,869
+51,774
| +50% | +$2.27M |
|
764
Kinder Morgan
KMI
$70.1B
| $6.68M | 0.02% |
369,858
+20,888
| +6% | +$376K |
|
|
BRKL
765
DELISTED
Brookline Bancorp
BRKL
| $6.67M | 0.02% |
471,097
+104,881
| +29% | +$1.4M |
|
766
Digital Realty Trust
DLR
$70.6B
| $6.66M | 0.02% |
66,418
-46,947
| -41% | -$4.79M |
|
767
BJs Wholesale Club
BJ
$12B
| $6.65M | 0.02% |
101,104
-193,122
| -66% | -$14M |
|
768
Oneok
OKE
$57.7B
| $6.64M | 0.02% |
101,333
-3,975
| -4% | -$244K |
|
769
GoPro
GPRO
$114M
| $6.63M | 0.02% |
1,332,161
+340,157
| +34% | +$1.78M |
|
770
Beazer Homes USA
BZH
$874M
| $6.63M | 0.02% |
519,290
+302,939
| +140% | +$3.68M |
|
771
A.O. Smith
AOS
$8.65B
| $6.62M | 0.02% |
115,755
-132,782
| -53% | -$7.42M |
|
772
Photronics
PLAB
$1.95B
| $6.61M | 0.02% |
392,802
+37,771
| +11% | +$644K |
|
773
Titan International
TWI
$461M
| $6.6M | 0.02% |
430,596
+88,465
| +26% | +$1.26M |
|
774
Customers Bancorp
CUBI
$2.8B
| $6.58M | 0.02% |
232,254
+59,703
| +35% | +$1.86M |
|
775
MillerKnoll
MLKN
$1.62B
| $6.56M | 0.02% |
316,411
+167,282
| +112% | +$3.35M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.